Diamond ML - Search Results

1

Serotonin syndrome induced by transitioning from phenelzine to venlafaxine: four patient reports.

Diamond S, Pepper BJ, Diamond ML, Freitag FG, Urban GJ, Erdemoglu AK. Diamond S, et al. Among authors: diamond ml. Neurology. 1998 Jul;51(1):274-6. doi: 10.1212/wnl.51.1.274. Neurology. 1998. PMID: 9674820

2

Emergency treatment of headache.

Freitag FG, Diamond M. Freitag FG, et al. Med Clin North Am. 1991 May;75(3):749-61. doi: 10.1016/s0025-7125(16)30447-3. Med Clin North Am. 1991. PMID: 2020227

3

Emergency treatment of migraine. Insights into current options.

Diamond S, Diamond ML. Diamond S, et al. Among authors: diamond ml. Postgrad Med. 1997 Jan;101(1):169-72, 175-6, 179. doi: 10.3810/pgm.1997.01.147. Postgrad Med. 1997. PMID: 9008695 Review.

4

Divalproex in the long-term treatment of chronic daily headache.

Freitag FG, Diamond S, Diamond ML, Urban GJ. Freitag FG, et al. Among authors: diamond s, diamond ml. Headache. 2001 Mar;41(3):271-8. doi: 10.1046/j.1526-4610.2001.111006271.x. Headache. 2001. PMID: 11264687

5

Migraine diagnosis and treatment: results from the American Migraine Study II.

Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Lipton RB, et al. Among authors: diamond s, diamond ml. Headache. 2001 Jul-Aug;41(7):638-45. doi: 10.1046/j.1526-4610.2001.041007638.x. Headache. 2001. PMID: 11554951

6

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Lipton RB, et al. Among authors: diamond s, diamond ml. Headache. 2001 Jul-Aug;41(7):646-57. doi: 10.1046/j.1526-4610.2001.041007646.x. Headache. 2001. PMID: 11554952

7

The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine.

Diamond ML. Diamond ML. Neurology. 2002 May 14;58(9 Suppl 6):S3-9. doi: 10.1212/wnl.58.9_suppl_6.s3. Neurology. 2002. PMID: 12011267 Review.

8

Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine.

Silberstein S, Tepper S, Brandes J, Diamond M, Goldstein J, Winner P, Venkatraman S, Vrijens F, Malbecq W, Lines C, Visser WH, Reines S, Yuen E. Silberstein S, et al. Neurology. 2004 May 11;62(9):1552-7. doi: 10.1212/01.wnl.0000123260.61631.c4. Neurology. 2004. PMID: 15136680 Clinical Trial.

9

Migraine prevalence, disease burden, and the need for preventive therapy.

Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF; AMPP Advisory Group. Lipton RB, et al. Among authors: diamond m. Neurology. 2007 Jan 30;68(5):343-9. doi: 10.1212/01.wnl.0000252808.97649.21. Neurology. 2007. PMID: 17261680

10

Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).

Freitag FG, Finlayson G, Rapoport AM, Elkind AH, Diamond ML, Unger JR, Fisher AC, Armstrong RB, Hulihan JF, Greenberg SJ; AIMS Investigators. Freitag FG, et al. Among authors: diamond ml. Headache. 2007 Apr;47(4):519-30. doi: 10.1111/j.1526-4610.2007.00756.x. Headache. 2007. PMID: 17445101 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page